• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内细胞外pH值:同基因肿瘤细胞系中化疗反应的一个有用参数。

Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines.

作者信息

Lindner D, Raghavan D

机构信息

Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH 44195, USA.

出版信息

Br J Cancer. 2009 Apr 21;100(8):1287-91. doi: 10.1038/sj.bjc.6605022.

DOI:10.1038/sj.bjc.6605022
PMID:19367285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2676543/
Abstract

Reliable surrogate markers of response to anticancer therapy remain a desirable tool for preclinical modelling and clinical practice in oncology. Clinical evaluation is relatively unreliable when attempting to assess rapidly and prospectively the outcome of treatment. Fluxes in released or circulating tumour marker levels are a useful but inconsistent marker of cytotoxic response. Serial measurement of circulating tumour cells appears to have some utility as a surrogate marker, but assay systems are expensive, and many cancers are not associated with the presence of circulating tumour cells. Because tissue breakdown is associated with release of nucleic acids and other cellular products, we reasoned that serial measurement of intra-tumoural pH may correlate with the extent of tumour lysis, and thus with outcomes of cytotoxic chemotherapy. Doxorubicin-sensitive and doxorubicin-resistant sublines of P388 murine monocytic leukaemia in C57BL/6 mice were treated with increasing concentrations of doxorubicin. Tumours were serially measured by conventional bi-dimensional methods and pH was sampled using a bevelled tip electrode. Mean and median pH changes were statistically different in responsive and resistant tumours, and amplitude of change correlated with long-term responses to doxorubicin. Serial sampling of pH in tumour masses may provide a useful surrogate of long-term response to chemotherapy.

摘要

可靠的抗癌治疗反应替代标志物仍然是肿瘤学临床前建模和临床实践中所期望的工具。在试图快速且前瞻性地评估治疗结果时,临床评估相对不可靠。释放或循环肿瘤标志物水平的变化是细胞毒性反应的一个有用但并不一致的标志物。循环肿瘤细胞的连续测量似乎作为替代标志物有一定作用,但检测系统昂贵,而且许多癌症与循环肿瘤细胞的存在并无关联。由于组织分解与核酸及其他细胞产物的释放有关,我们推断肿瘤内pH值的连续测量可能与肿瘤溶解程度相关,进而与细胞毒性化疗的结果相关。用递增浓度的阿霉素处理C57BL/6小鼠中的P388鼠单核细胞白血病的阿霉素敏感和阿霉素耐药亚系。通过传统的二维方法对肿瘤进行连续测量,并使用斜角尖端电极对pH值进行采样。反应性和耐药性肿瘤的平均和中位数pH变化在统计学上有差异,且变化幅度与对阿霉素的长期反应相关。肿瘤块中pH值的连续采样可能为化疗的长期反应提供一个有用的替代指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/69ed01bc80c5/6605022f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/c2d54db46413/6605022f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/b9fe83df9e31/6605022f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/4ef68b1abb32/6605022f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/1d18b3084e4b/6605022f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/0690a5ce4e2c/6605022f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/69ed01bc80c5/6605022f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/c2d54db46413/6605022f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/b9fe83df9e31/6605022f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/4ef68b1abb32/6605022f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/1d18b3084e4b/6605022f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/0690a5ce4e2c/6605022f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e590/2676543/69ed01bc80c5/6605022f6.jpg

相似文献

1
Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines.肿瘤内细胞外pH值:同基因肿瘤细胞系中化疗反应的一个有用参数。
Br J Cancer. 2009 Apr 21;100(8):1287-91. doi: 10.1038/sj.bjc.6605022.
2
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.FCE 23762(一种对阿霉素耐药肿瘤细胞有活性的阿霉素甲氧基吗啉基衍生物)的体内抗肿瘤活性
Br J Cancer. 1992 May;65(5):703-7. doi: 10.1038/bjc.1992.148.
3
Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
Anticancer Res. 1994 Sep-Oct;14(5A):1995-2003.
4
SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.SDZ 280 - 446,一种新型半合成环肽内酯:体外和体内对P-糖蛋白介导的肿瘤细胞多药耐药性的规避
Br J Cancer. 1992 Jan;65(1):11-8. doi: 10.1038/bjc.1992.3.
5
An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.一种用于评估白血病细胞化学敏感性的体外试验:临床前研究
Int J Tissue React. 1986;8(6):485-92.
6
[The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].[对阿霉素诱导耐药的白血病P388细胞的细胞生长抑制剂交叉耐药性]
Biull Eksp Biol Med. 1993 Sep;116(9):309-11.
7
Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.
Jpn J Pharmacol. 1990 Dec;54(4):464-7. doi: 10.1254/jjp.54.464.
8
In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
Oncology. 1990;47(2):166-9. doi: 10.1159/000226811.
9
N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.N-苄基阿霉素-14-戊酸酯与逐渐对阿霉素耐药的鼠肿瘤:细胞药理学及体内外交叉耐药性的特征分析
Br J Cancer. 1989 Dec;60(6):819-26. doi: 10.1038/bjc.1989.373.
10
Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.钙调蛋白抑制剂三氟拉嗪增强耐药P388白血病对阿霉素的敏感性
Cancer Res. 1983 Aug;43(8):3696-9.

引用本文的文献

1
Selectivity of membrane-active peptides: the role of electrostatics and other membrane biophysical properties.膜活性肽的选择性:静电作用及其他膜生物物理性质的作用
Biophys Rev. 2025 Apr 10;17(2):591-604. doi: 10.1007/s12551-025-01309-7. eCollection 2025 Apr.
2
Functional Imaging of Hypoxia: PET and MRI.缺氧的功能成像:正电子发射断层扫描(PET)和磁共振成像(MRI)
Cancers (Basel). 2023 Jun 25;15(13):3336. doi: 10.3390/cancers15133336.
3
Acidic extracellular pH induces autophagy to promote anoikis resistance of hepatocellular carcinoma cells via downregulation of miR-3663-3p.

本文引用的文献

1
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.循环肿瘤细胞可预测转移性去势抵抗性前列腺癌患者从治疗中获得的生存益处。
Clin Cancer Res. 2008 Oct 1;14(19):6302-9. doi: 10.1158/1078-0432.CCR-08-0872.
2
Drug resistance and the solid tumor microenvironment.耐药性与实体瘤微环境
J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54. doi: 10.1093/jnci/djm135. Epub 2007 Sep 25.
3
Tumor lysis syndrome.肿瘤溶解综合征
酸性细胞外pH值通过下调miR-3663-3p诱导自噬,以促进肝癌细胞的失巢凋亡抗性。
J Cancer. 2021 Apr 19;12(12):3418-3426. doi: 10.7150/jca.51849. eCollection 2021.
4
FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity.FcRn 是一种 CD32a 辅助受体,决定了对 IgG 免疫复合物驱动的自身免疫的易感性。
J Exp Med. 2020 Oct 5;217(10). doi: 10.1084/jem.20200359.
5
A Ln(III)-3-hydroxypyridine pH responsive probe optimized by DFT.一种通过密度泛函理论(DFT)优化的镧(III)-3-羟基吡啶pH响应探针。
RSC Adv. 2020;10(15):8994-8999. doi: 10.1039/c9ra11058e. Epub 2020 Mar 3.
6
Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.沙利霉素作为自噬调节剂——抗癌的新途径:综述。
J Exp Clin Cancer Res. 2018 Feb 13;37(1):26. doi: 10.1186/s13046-018-0680-z.
7
ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca/RhoA pathway.ASIC1 和 ASIC3 通过激活 Ca/RhoA 通路促进胰腺癌酸性诱导的 EMT。
Cell Death Dis. 2017 May 18;8(5):e2806. doi: 10.1038/cddis.2017.189.
8
Single-cell pH imaging and detection for pH profiling and label-free rapid identification of cancer-cells.单细胞 pH 成像和检测用于 pH profiling 以及无标记的快速癌细胞鉴定。
Sci Rep. 2017 May 11;7(1):1759. doi: 10.1038/s41598-017-01956-1.
9
Nitric oxide and pH modulation in gynaecological cancer.妇科癌症中的一氧化氮与pH调节
J Cell Mol Med. 2016 Dec;20(12):2223-2230. doi: 10.1111/jcmm.12921. Epub 2016 Jul 29.
10
Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells.肿瘤酸中毒增强了沙利霉素对癌细胞系和癌症干细胞的细胞毒性作用及自噬抑制作用。
Oncotarget. 2016 Jun 14;7(24):35703-35723. doi: 10.18632/oncotarget.9601.
Semin Thromb Hemost. 2007 Jun;33(4):397-407. doi: 10.1055/s-2007-976175.
4
TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.在酸性细胞外环境下,肿瘤坏死因子相关凋亡诱导配体(TRAIL)可诱导受体相互作用蛋白1依赖性和半胱天冬酶依赖性的坏死样细胞死亡。
Cancer Res. 2007 Jan 1;67(1):218-26. doi: 10.1158/0008-5472.CAN-06-1610.
5
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.循环肿瘤细胞与影像学——预测转移性乳腺癌的总生存期
Clin Cancer Res. 2006 Nov 1;12(21):6403-9. doi: 10.1158/1078-0432.CCR-05-1769.
6
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).雄激素剥夺治疗后的前列腺特异性抗原绝对值是新诊断转移性前列腺癌患者生存的有力独立预测指标:来自西南肿瘤协作组9346试验(INT-0162)的数据
J Clin Oncol. 2006 Aug 20;24(24):3984-90. doi: 10.1200/JCO.2006.06.4246.
7
TRAIL (TNF-related apoptosis-inducing ligand) induces necrosis-like cell death in tumor cells at acidic extracellular pH.
Ann N Y Acad Sci. 2005 Nov;1056:379-87. doi: 10.1196/annals.1352.018.
8
RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma.RECIST 与 WHO 标准对比:在一项欧洲癌症研究与治疗组织(EORTC)的 II 期临床试验中对晚期软组织肉瘤患者使用 ET-743 治疗时疗效评估标准的前瞻性比较。
Eur J Cancer. 2005 Jul;41(10):1426-30. doi: 10.1016/j.ejca.2005.04.005.
9
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.循环肿瘤细胞、疾病进展与转移性乳腺癌患者的生存情况
N Engl J Med. 2004 Aug 19;351(8):781-91. doi: 10.1056/NEJMoa040766.
10
Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society.实体瘤治疗反应评估——国际癌症成像协会的共识声明
Br J Cancer. 2004 Jun 14;90(12):2256-60. doi: 10.1038/sj.bjc.6601843.